Jon Rees
Chief Executive Officer & Co-Founder, MitoRx Therapeutics
Developing small-molecule weight loss therapy in obesity addressing the key unmet need: avoiding the metabolic trap set by GLP-1s, targeted fat loss with preservation of lean mass and muscle function.
Events Jon Rees has spoken at
- BioTrinity 2026 14 April 2026 – 15 April 2026